Uncategorized


October 29, 2026

[CNC, MOH, HCA, THC, UHS] Medicaid Work Requirements: Court Ruling, State Flexibility Temper Disenrollment Fears

By Beth Steindecker

We view today’s federal court ruling broadening medical frailty exemptions from the Medicaid expansion work and community engagement requirements as incrementally favorable for Medicaid insurers [CNC, MOH, ELV] and acute care and behavioral hospitals [HCA,…

Read More >>

October 29, 2026

(DKNG, FLUT, HOOD, CME) Prediction Markets: Utah Escalates the Battle as Democrats Prepare to Investigate

By Joe Lieber

Utah’s decision yesterday to file criminal charges against Kalshi and its founders marks the latest escalation in the battle over prediction markets and could help accelerate a likely U.S. Supreme Court review of the dispute….

Read More >>

October 29, 2026

[DVA, FRE.DE, Innovative Renal, American Renal] Better-Than-Expected Headline Spending Increase in Final CY27 Rule Masks Some Dialysis Pressures

By Beth Steindecker

At first glance, CMS’s final CY27 Medicare end-stage renal disease (ESRD) payment rule, released late Wednesday, seems more favorable than expected for dialysis centers [DVA, FRE.DE, private Innovative Renal and American Renal]. CMS projected a…

Read More >>

October 27, 2026

Democrats Are Closing in on Congressional Control, but Could Fetterman Change the Outcome?

By Joe Lieber

With one week until the midterm elections, we continue to put the odds of Democrats retaking the House at more than 85%, and we expect them to emerge with a 12–17-seat majority when all is…

Read More >>

October 26, 2026

[OSCR, CNC, ELV, HCA, THC, DVA, FRE.DE] ACA Verification Proposal Tests, Rather Than Resets, Exchange Stabilization

By Beth Steindecker

We view CMS’s 2028 ACA pre-eligibility verification proposal, released late Friday, as an incremental risk to exchange insurers [OSCR, CNC, ELV] and hospitals and dialysis centers [HCA, THC, ADRT, DVA, FRE.DE], rather than a new…

Read More >>

October 21, 2026

ABT & CMS’s Cologuard Plus Rate Risks

By John Leppard

CMS’s release of its preliminary PAMA rate determinations earlier this week for lab services without private payer data implies a 14.9% reduction in ABT’s [EXAS] Cologuard Plus payments next year, taking the Medicare FFS rate…

Read More >>

October 20, 2026

[DVA, FRE.DE] HHS Kidney Plan: Less of a Plan, More of a Think Piece; Low Near-Term Policy Risk

By Beth Steindecker

Below are our thoughts on this afternoon’s HHS release of the National Kidney Dialysis Plan [DVA, FRE.DE, private US Renal, Innovative Renal Care]: The stock reaction [DVA, FRE.DE] seems overblown, especially given the limited near-term…

Read More >>

October 19, 2026

Republicans May Have More Support Than the Polls Suggest

By Joe Lieber

There are some reasons to believe the Republicans could perform better than current polling suggests, despite the fact that the political environment remains difficult for the GOP, with President Trump’s overall approval rating at just…

Read More >>

October 18, 2026

[HUM, ALHC, UNH, CVS, ELV, AGL, ASTH] Medicare Advantage: Friday’s Proposal Leaves Bigger Questions Unanswered

By Beth Steindecker

Questions remain about potential CY28 policy pressures on Medicare Advantage (MA) insurers [HUM, ALHC, CLOV, UNH, CVS, ELV, CNC, MOH] and value-based care providers [AGL, ASTH, PRVA, EVH, private Aledade], particularly Star Ratings, risk adjustment,…

Read More >>

October 16, 2026

[NUTX, TeamHealth, Radiology Partners, SCP Health, UNH, CI, ELV] NSA Reform: Arbitration Under Fire, but Benchmark Shift Unlikely

By Beth Steindecker

Recent developments are raising the risk of future changes to the No Surprises Act, with implications for specialty physicians and hospitals [NUTX, private TeamHealth, Radiology Partners, SCP Health] and commercial insurers [UNH, CI, ELV, CVS]….

Read More >>